The Latest SPAC News and Rumors: June 20, 2023
by Marlena Haddad on 2023-06-20 at 11:31am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  Volocopter to serve Paris Olympics, ZeroNox announces product development agreement with Kubota Corp., and Spectral MD completes audit for its DeepView Wound Imaging System


Air taxi maker races to serve Paris Olympics as sector struggles for funds

A year ahead of the Paris Olympics, flying taxi maker Volocopter wants to prove to executives at the Paris Airshow it is on track to ferry customers around the sporting showcase and take off globally.

The world’s largest air show tends to focus on military and commercial planes. But electric vertical takeoff and landing (eVTOL) aircraft makers are also there in force, with Lilium announcing a deal on Monday for China’s HeliShenzhen Eastern General Aviation Co. to buy 100 of its jets.

Volocopter had initially planned to go public via a SPAC, but ultimately ended up canceling those plans in 2021.

READ

ZeroNox Announces Product Development Agreement with Kubota Corporation

Zero Nox Inc. a leading provider of sustainable, off-highway vehicle electrification, today announced a product development agreement for currently undisclosed products with Kubota Corporation in Japan.

Under the terms of the agreement, ZeroNox and KBT have entered a product development agreement to electrify select undisclosed products. Further details of the products included in the product development agreement will be disclosed at a later date.

As previously announced, ZeroNox signed a definitive business combination agreement with The Growth for Good Acquisition Corp. (Nasdaq: GFGD).

READ

Spectral MD Holdings Completion of ISO 13485 Certification Audit

Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces it has completed the quality management ISO 13485 certification audit for the manufacture and distribution of its DeepView® Wound Imaging System. ISO 13485 certification has now been recommended and is anticipated in Q3 2023. The completion of the audit validates Spectral MD’s commitment to meeting the highest standards of quality, reliability, and safety in the medical device industry.

As announced on April 11, Spectral MD Holdings has entered into a business combination agreement to combine with Rosecliff Acquisition Corp I (“Rosecliff”, Nasdaq: RCLF).

READ

 

The Latest SPAC News and Rumors: June 20, 2023
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved